W.W. Grainger, Inc.
NYSE:GWWIndustrial - Distribution
+$39.83 today
- Market cap
- $67.79B
- Beta
- 1.05
- P/E (TTM)
- 35.9
- EPS (TTM)
- $37.67
- Dividend yield
- 0.69%
Volume 0.34M
Average 0.26M
GWW Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
W.W. Grainger, Inc.NYSE: GWW
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How GWW compares with its peers on the latest reported figures
- GWW's LTM Jun 2026 research & development of $0 is the highest of the 7 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for GWW, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GWW) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for GWW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.02B | 15.23B | 16.48B | 17.17B | 17.94B |
| Cost of Revenue | 8.3B | 9.38B | 9.98B | 10.48B | 10.93B |
| Gross Profit | 4.72B | 5.85B | 6.5B | 6.69B | 7.01B |
| Gross Margin | 36.2% | 38.4% | 39.4% | 39.0% | 39.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.17B | 3.63B | 3.93B | 4.02B | 4.32B |
| Operating Expenses | 3.17B | 3.63B | 3.93B | 4.05B | 4.32B |
| Depreciation & Amortization | 187M | 205M | 214M | 237M | 254M |
| EBITDA | 1.74B | 2.41B | 2.81B | 2.9B | 2.77B |
| EBITDA Margin | 13.4% | 15.8% | 17.0% | 16.9% | 15.4% |
| Operating Income | 1.55B | 2.22B | 2.57B | 2.64B | 2.69B |
| Operating Margin | 11.9% | 14.5% | 15.6% | 15.4% | 15.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 87M | 93M | 93M | 77M | 81M |
| Other Income / Expenses | (62M) | (69M) | (65M) | (53M) | (261M) |
| Income Before Tax | 1.49B | 2.15B | 2.5B | 2.58B | 2.43B |
| Pre-Tax Margin | 11.4% | 14.1% | 15.2% | 15.1% | 13.5% |
| Income Tax Expense | 371M | 533M | 597M | 595M | 622M |
| Net Income | 1.04B | 1.55B | 1.83B | 1.91B | 1.71B |
| Net Margin | 8.0% | 10.2% | 11.1% | 11.1% | 9.5% |
| EPS (Basic) | 20.10 | 30.39 | 36.65 | 39.04 | 35.47 |
| EPS (Diluted) | 19.98 | 30.27 | 36.51 | 38.71 | 35.40 |
| Weighted Avg Shares | 51.9M | 50.9M | 49.9M | 48.9M | 47.9M |
| Weighted Avg Shares (Diluted) | 52.2M | 51.1M | 50.1M | 49M | 48M |
W.W. Grainger, Inc.
NYSE:GWW
Intrinsic Alpha fair value
Locked
Current Price
$1,448.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.